Miconazole - Revision history

Danbot: Remove disease-specific subsections now covered by AntibioticDose on disease pages

2026-03-20T12:34:56Z

Remove disease-specific subsections now covered by AntibioticDose on disease pages

@@ Line 6: / Line 6: @@
 ==Adult Dosing==
 ===Indications by Disease===
 {{#ask: [[Has DrugName::Miconazole]] [[Has Population::Adult]]
@@ Line 28: / Line 19: @@
 ==Pediatric Dosing==
-===[[Candidiasis]], cutaneous===
+Same as adult
 ===Indications by Disease===

Danbot: Fix corrupted content: restore correct Miconazole (antifungal) content, was incorrectly showing Mirtazapine

2026-03-20T12:11:53Z

Fix corrupted content: restore correct Miconazole (antifungal) content, was incorrectly showing Mirtazapine

← Older revision		Revision as of 12:11, 20 March 2026
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: ~~Atypical antidepressant~~		*Type: [[Antifungal]]
	*Dosage Forms:		*Dosage Forms: 2% Cream
	*Routes of Administration: ~~oral~~		*Routes of Administration: Topical
	*Common Trade Names: ~~Remeron~~		*Common Trade Names: Monistat-Derm, Desenex, Lotrimin, Micatin, Zeasorb

	==Adult Dosing==		==Adult Dosing==
	*~~15-45mg PO nightly~~		===[[Candidiasis]], cutaneous===
			*Apply 2% Cream BID to affected area x2 weeks
			===[[Tinea corporis]]===
			*Apply 2% Cream BID to affected area x4 weeks
			===[[Tinea cruris]]===
			*Apply 2% Cream BID to affected area x2 weeks
			===[[Tinea pedis]]===
			*Apply 2% Cream BID to affected area x4 weeks

	===Indications by Disease===		===Indications by Disease===
Line 22:		Line 28:

	==Pediatric Dosing==		==Pediatric Dosing==
	~~''Safety/efficacy not established''~~		===[[Candidiasis]], cutaneous===
			*Apply 2% Cream BID to affected area x2 weeks
			===[[Tinea corporis]]===
			*Apply 2% Cream BID to affected area x4 weeks
			===[[Tinea cruris]]===
			*Apply 2% Cream BID to affected area x2 weeks
			===[[Tinea pedis]]===
			*Apply 2% Cream BID to affected area x4 weeks

	===Indications by Disease===		===Indications by Disease===
Line 38:		Line 50:

	==Special Populations==		==Special Populations==
	*[[Drug pregnancy categories\|Pregnancy Rating]]~~: C~~		===[[Drug pregnancy categories\|Pregnancy Rating]]===
	*Lactation risk~~: Infant risk cannot be ruled out~~		*Risk of fetal harm not expected
	*Renal ~~dosing, CrCl <40~~: ~~increase dose slowly~~		*May use during pregnancy
	*Hepatic ~~impairment~~: ~~increase dose slowly~~		===Lactation risk===
			*May use while breastfeeding
			===Renal Dosing===
			*Adult: No adjustment needed
			*Pediatric: No adjustment needed
			===Hepatic Dosing===
			*Adult: No adjustment needed
			*Pediatric: No adjustment needed

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
	*MAOI use concomitantly or within past 14 days

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*~~Agranulocytosis, neutropenia~~		*[[Anaphylaxis]] (rare)
	*Neuroleptic malignant syndrome, serotonin syndrome
	*Seizure, status epilepticus
	*Exacerbation of depression, suicidality
	*Cirrhosis
	===Common===		===Common===
	*~~Increased appetite, weight gain, elevated triglycerides, constipation, xerostomia~~		*Skin irritation
	*~~Dizziness, somnolence, disturbance in thinking~~		*Burning
			*Pruritus

	==Pharmacology==		==Pharmacology==
	*Half-life: 26-37h		*Metabolism: Hepatic
	*Metabolism: Hepatic~~, CYP2D6, CYP1A2, and CYP3A4~~		*Info: Minimal systemic absorption from topical use
	*~~Excretion~~: ~~Mostly renal~~

	==Mechanism of Action==		==Mechanism of Action==
	*~~Exact mechanism of action unknown. Potent serotonin 5HT2 and 5HT3 antagonist, moderate muscarinic antagonist. Side effects due to antihistaminergic and α-1 antagonist properties~~		*Azole antifungal
			**Inhibits ergosterol synthesis in fungal cell membranes
	~~==Comments==~~


	==See Also==		==See Also==
	*[[~~Depression~~]]		*[[Antifungals]]
			*[[Candidiasis]]
			*[[Tinea corporis]]

	==References==		==References==
Line 76:		Line 90:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:~~Psychiatry~~]]		[[Category:ID]]

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:39:30Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:39, 20 March 2026
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: ~~[[Antifungal]]~~		*Type: Atypical antidepressant
	*Dosage Forms: ~~2% Cream~~		*Dosage Forms:
	*Routes of Administration: ~~Topical~~		*Routes of Administration: oral
	*Common Trade Names: ~~Monistat-Derm, Desenex, Lotrimin, Micatin, Zeasorb~~		*Common Trade Names: Remeron

	==Adult Dosing==		==Adult Dosing==
			*15-45mg PO nightly


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			''Safety/efficacy not established''


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Special Populations==		==Special Populations==
	~~===~~[[Drug pregnancy categories\|Pregnancy Rating]]~~===~~		*[[Drug pregnancy categories\|Pregnancy Rating]]: C
	*Risk of fetal harm no expected		*Lactation risk: Infant risk cannot be ruled out
	*~~May use during pregnancy~~		*Renal dosing, CrCl <40: increase dose slowly
			*Hepatic impairment: increase dose slowly
	~~===~~Lactation risk~~===~~
	*~~May use while breastfeeding~~

	~~===~~Renal ~~Dosing===~~
	*Adult: ~~Not defined~~
	*~~Pediatric: Not defined~~

	~~===~~Hepatic ~~Dosing===~~
	*Adult: Not defined
	*Pediatric: ~~Not defined~~

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
			*MAOI use concomitantly or within past 14 days

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*~~May occur~~, ~~but none reported~~		*Agranulocytosis, neutropenia
			*Neuroleptic malignant syndrome, serotonin syndrome
			*Seizure, status epilepticus
			*Exacerbation of depression, suicidality
			*Cirrhosis
	===Common===		===Common===
	*~~Irritation~~, ~~burning~~, ~~stining~~		*Increased appetite, weight gain, elevated triglycerides, constipation, xerostomia
	*~~[[Pruritus]]~~, ~~erythema~~, ~~maceration~~		*Dizziness, somnolence, disturbance in thinking
	*[[Contact dermatitis]]

	==Pharmacology==		==Pharmacology==
	*Half-life: ~~Unknown~~		*Half-life: 26-37h
	*Metabolism: ~~None~~, ~~minimal systemic absorption~~		*Metabolism: Hepatic, CYP2D6, CYP1A2, and CYP3A4
	*Excretion: ~~None~~		*Excretion: Mostly renal

	==Mechanism of Action==		==Mechanism of Action==
	*~~Inhibits 14~~-~~alpha demethylase, reducing fungal cell membrane ergosterol synthesis~~		*Exact mechanism of action unknown. Potent serotonin 5HT2 and 5HT3 antagonist, moderate muscarinic antagonist. Side effects due to antihistaminergic and α-1 antagonist properties

	==Comments==		==Comments==
Line 71:		Line 70:

	==See Also==		==See Also==
	*[[~~Antifungals]]~~		*[[Depression]]
	*[[Fungal infections]]

	==References==		==References==
	<references/>		<references/>

	[[Category:Pharmacology]] [[Category:ID]]		[[Category:Pharmacology]]
			[[Category:Psychiatry]]

Danbot: Replace manual dosing with dynamic SMW tables

2026-03-20T01:54:39Z

Replace manual dosing with dynamic SMW tables

← Older revision		Revision as of 01:54, 20 March 2026
Line 6:		Line 6:

	==Adult Dosing==		==Adult Dosing==
	===~~[[Candidiasis]], cutaneous~~===		===Indications by Disease===
	*Apply 2% Cream BID to affected area x2 weeks		{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Adult]]
	~~===~~[[~~Tinea corporis~~]]~~===~~		\|?Treats disease=Disease
	*Apply 2% Cream BID to affected area x4 weeks		\|?Has Dose=Dose
	~~===~~[[~~Tinea cruris~~]]===		\|?Has Context=Context
	*Apply 2% Cream BID to affected area x2 weeks		\|format=table
	===~~[[Tinea pedis]]==~~=		\|limit=50
	*Apply 2% Cream BID to affected area x4 weeks		\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~[[Candidiasis]], cutaneous~~===		===Indications by Disease===
	*Apply 2% Cream BID to affected area x2 weeks		{{#ask: [[Has DrugName::Miconazole]] [[Has Population::Pediatric]]
	~~===~~[[~~Tinea corporis~~]]~~===~~		\|?Treats disease=Disease
	*Apply 2% Cream BID to affected area x4 weeks		\|?Has Dose=Dose
	~~===~~[[~~Tinea cruris~~]]===		\|?Has Context=Context
	*Apply 2% Cream BID to affected area x2 weeks		\|format=table
	===~~[[Tinea pedis]]==~~=		\|limit=50
	*Apply 2% Cream BID to affected area x4 weeks		\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

Elcatracho: /* See Also */

2021-03-08T03:20:57Z

ClaireLewis at 23:27, 22 September 2019

2019-09-22T23:27:54Z

← Older revision		Revision as of 23:27, 22 September 2019
Line 70:		Line 70:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Jonwarren: Creation of page

2018-12-31T20:12:00Z

Creation of page

New page

==Administration==
*Type: [[Antifungal]]
*Dosage Forms: 2% Cream
*Routes of Administration: Topical
*Common Trade Names: Monistat-Derm, Desenex, Lotrimin, Micatin, Zeasorb

==Adult Dosing==
===[[Candidiasis]], cutaneous===
*Apply 2% Cream BID to affected area x2 weeks
===[[Tinea corporis]]===
*Apply 2% Cream BID to affected area x4 weeks
===[[Tinea cruris]]===
*Apply 2% Cream BID to affected area x2 weeks
===[[Tinea pedis]]===
*Apply 2% Cream BID to affected area x4 weeks

==Pediatric Dosing==
===[[Candidiasis]], cutaneous===
*Apply 2% Cream BID to affected area x2 weeks
===[[Tinea corporis]]===
*Apply 2% Cream BID to affected area x4 weeks
===[[Tinea cruris]]===
*Apply 2% Cream BID to affected area x2 weeks
===[[Tinea pedis]]===
*Apply 2% Cream BID to affected area x4 weeks

==Special Populations==
===[[Drug pregnancy categories|Pregnancy Rating]]===
*Risk of fetal harm no expected
*May use during pregnancy

===Lactation risk===
*May use while breastfeeding

===Renal Dosing===
*Adult: Not defined
*Pediatric: Not defined

===Hepatic Dosing===
*Adult: Not defined
*Pediatric: Not defined

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*May occur, but none reported

===Common===
*Irritation, burning, stining
*[[Pruritus]], erythema, maceration
*[[Contact dermatitis]]

==Pharmacology==
*Half-life: Unknown
*Metabolism: None, minimal systemic absorption
*Excretion: None

==Mechanism of Action==
*Inhibits 14-alpha demethylase, reducing fungal cell membrane ergosterol synthesis

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]

← Older revision		Revision as of 03:20, 8 March 2021
Line 65:		Line 65:

	==See Also==		==See Also==
			*[[Antifungals]]
			*[[Fungal infections]]

	==References==		==References==